Women's imaging firm Hologic is touting six-year follow-up results from the American Society of Breast Surgeons (ASBS) MammoSite Registry Study.
The study of more than 1,400 patients shows "excellent/good" cosmetic results in 90.4% of the cases, the company said.
Dr. Peter Beitsch, a surgeon at the Dallas Breast Center and lead author of the study, said that positive data from the MammoSite Registry has contributed to the acceptance of accelerated partial-breast irradiation (APBI) across the U.S. and the world.
Results were presented at the American Society for Radiation Oncology (ASTRO) meeting in Miami Beach, FL, this week.
